Use of cortisone in erythema nodosum. 1951

S FARBER, and H MANDELBAUM

UI MeSH Term Description Entries
D003348 Cortisone A naturally occurring glucocorticoid that has been used in replacement therapy for ADRENAL INSUFFICIENCY and as an anti-inflammatory agent. Cortisone itself is inactive; it is converted in the liver to the active metabolite HYDROCORTISONE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p726) 17-Hydroxy-3,11,20-trioxopregn-4-en-21-yl acetate,Adreson,Cortisone Acetate,Cortone Acetate
D004893 Erythema Nodosum An erythematous eruption commonly associated with drug reactions or infection and characterized by inflammatory nodules that are usually tender, multiple, and bilateral. These nodules are located predominantly on the shins with less common occurrence on the thighs and forearms. They undergo characteristic color changes ending in temporary bruise-like areas. This condition usually subsides in 3-6 weeks without scarring or atrophy.

Related Publications

S FARBER, and H MANDELBAUM
April 1956, Therapie der Gegenwart,
S FARBER, and H MANDELBAUM
October 1952, Journal of the American Medical Association,
S FARBER, and H MANDELBAUM
November 1955, The Journal of the American Osteopathic Association,
S FARBER, and H MANDELBAUM
November 1953, New York state journal of medicine,
S FARBER, and H MANDELBAUM
November 1951, California medicine,
S FARBER, and H MANDELBAUM
April 1954, La Presse medicale,
S FARBER, and H MANDELBAUM
July 1951, The New England journal of medicine,
S FARBER, and H MANDELBAUM
July 1947, Virginia medical monthly,
S FARBER, and H MANDELBAUM
December 2002, Journal of the American Academy of Dermatology,
S FARBER, and H MANDELBAUM
February 1954, Postgraduate medicine,
Copied contents to your clipboard!